Synthetic organic

D-cycloserine.

D4476, a cell-permeant inhibitor of CK1δ (IC90 &lt:10 uM), originally identified as inhibitors of activin receptor-like kinase ALK5.A cell-permeable triaryl substituted imidazolo compound that acts as a selective inhibitor of casein kinase 1 (CK1).

D4476, a cell-permeant inhibitor of CK1δ (IC90 &lt:10 uM), originally identified as inhibitors of activin receptor-like kinase ALK5.A cell-permeable triaryl substituted imidazolo compound that acts as a selective inhibitor of casein kinase 1 (CK1).

D4476, a cell-permeant inhibitor of CK1δ (IC90 &lt:10 uM), originally identified as inhibitors of activin receptor-like kinase ALK5.A cell-permeable triaryl substituted imidazolo compound that acts as a selective inhibitor of casein kinase 1 (CK1).

D5261.

D5261.

D6808.

D6808.

Dabigatran Etexilate is the prodrug of dabigatran, a potent, nonpeptidic small molecule that specifically and reversibly inhibits both free and clot-bound thrombin by binding to the active site of the thrombin molecule.An anticoagulant from the

Dabigatran Etexilate is the prodrug of dabigatran, a potent, nonpeptidic small molecule that specifically and reversibly inhibits both free and clot-bound thrombin by binding to the active site of the thrombin molecule.An anticoagulant from the

Dabigatran Etexilate is the prodrug of dabigatran, a potent, nonpeptidic small molecule that specifically and reversibly inhibits both free and clot-bound thrombin by binding to the active site of the thrombin molecule.An anticoagulant from the

Dabigatran Etexilate is the prodrug of dabigatran, a potent, nonpeptidic small molecule that specifically and reversibly inhibits both free and clot-bound thrombin by binding to the active site of the thrombin molecule.An anticoagulant from the